These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13084042)

  • 21. [Expression of GLUT-1, p63 and DNA-Pkcs in serous ovarian tumors and their significance].
    Shao SL; Cai Y; Wang QH; Yan LJ; Zhao XY; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):697-700. PubMed ID: 18246802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immediate and remote results of operative treatment of malignant tumors of the ovaries].
    SIGALOV AB
    Akush Ginekol (Mosk); 1959; 35(3):106-9. PubMed ID: 13661017
    [No Abstract]   [Full Text] [Related]  

  • 24. Serous adenofibroma of ovary: An eccentric presentation.
    Shukla S; Srivastava D; Acharya S; Dhote S; Vagha S
    J Cancer Res Ther; 2015; 11(4):1030. PubMed ID: 26881611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic challenge of ovarian carcinoma in normal-sized ovaries: a report of two cases.
    Yong SL; Dahian S; Ramlan AH; Kang M
    Horm Mol Biol Clin Investig; 2018 Aug; 35(1):. PubMed ID: 30098285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
    Ludovisi M; Foo X; Mainenti S; Testa AC; Arora R; Jurkovic D
    J Clin Ultrasound; 2015; 43(9):573-7. PubMed ID: 25706035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical aspects of malignant ovarian tumors].
    KHOLIN VV
    Akush Ginekol (Mosk); 1954; 2():47-50. PubMed ID: 13148073
    [No Abstract]   [Full Text] [Related]  

  • 28. [The difficulties of diagnosis of malignant ovarian tumors].
    FROEWIS J; BROSCH H
    Krebsarzt; 1954 Oct; 9(5):282-5. PubMed ID: 13222795
    [No Abstract]   [Full Text] [Related]  

  • 29. [Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases].
    Yamazaki T; Hatano H; Suzuki A; Sugase M; Nakamura M; Sekiya M; Ueda N; Haba K; Tsukahara Y; Fujii S
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):27-34. PubMed ID: 7844450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on cytology and cytochemistry of cilioepithelial tumor cells in puncture of serous ovarian cystomas and cystadenocarcinomas].
    EBNER HJ
    Z Krebsforsch; 1953; 59(5):581-93. PubMed ID: 13170386
    [No Abstract]   [Full Text] [Related]  

  • 31. [Report on 186 cases of malignant ovarian tumors].
    ROTH F
    Z Geburtshilfe Gynakol; 1956; 145(2):207-22. PubMed ID: 13338378
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness and remote results of treatment of malignant ovarian tumors].
    FESIUK NV
    Akush Ginekol (Mosk); 1958; 34(4):72-5. PubMed ID: 13582751
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant tumors of the ovary.
    GARDINER GA; SLATE J
    Am J Obstet Gynecol; 1955 Sep; 70(3):554-62. PubMed ID: 13238499
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of malignant tumors of the ovaries; data of the P.A. Gertsen State Oncological Institute].
    ZIMINA AP
    Vopr Onkol; 1955; 1(1):67-73. PubMed ID: 13299750
    [No Abstract]   [Full Text] [Related]  

  • 35. Borderline malignant serous tumors of the ovary maintained on extracellular matrix: evidence for clonal evolution and invasive potential.
    Crickard K; Marinello MJ; Crickard U; Satchidanand SK; Yoonessi M; Caglar H
    Cancer Genet Cytogenet; 1986 Oct; 23(2):135-43. PubMed ID: 3756833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ovarian serous cystadenofibroma; a report of 25 cases.
    McNULTY JR
    Am J Obstet Gynecol; 1959 Jun; 77(6):1338-44. PubMed ID: 13649808
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant ovarian tumors.
    FALLS FH
    Postgrad Med; 1951 Dec; 10(6):465-8. PubMed ID: 14891530
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression pattern of RAGE and IGF-1 in the human fetal ovary and ovarian serous carcinoma.
    Poljicanin A; Filipovic N; Vukusic Pusic T; Soljic V; Caric A; Saraga-Babic M; Vukojevic K
    Acta Histochem; 2015; 117(4-5):468-76. PubMed ID: 25724694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Karyometry of the tumor epitheliocytes in the dysplastic sections of serous tumors and in serous cancers of the ovaries].
    Iakovtsova II
    Tsitol Genet; 1996; 30(6):12-5. PubMed ID: 9139432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.